Rijksinstituut voor Volksgezondheid en Milieu
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial | RIVM
Bron:
rivm.nl